WisdoMont Asset Management is an investment Firm.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
WisdoMont Asset Management is a Shengshan Assets is an excellent venture capital and private equity fund management company in China. Shengshan Assets closely monitors investment opportunities in medical health and smart big data under the trend of consumption upgrading.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2016 | Nanobubble | Angel Round | 456.1k |
5/2016 | Tenbent Insurance | Seed Round | 1.5M |
12/2016 | Tenbent Insurance | Series A | 1.5M |
5/2017 | Hongfund Financial | Angel Round | 0 |
8/2018 | BANGBANG ROBOT | Series A | - |
12/2018 | Cryofocus Biotech | Series A | 2.9M |
7/2015 | WEFANS | Series A | 0 |
7/2020 | OBiO Technology | Series C | 28.5M |
5/2017 | Yuan Qu | Series B | 2.9M |
3/2016 | Ruiquan Caring | Angel Round | - |
6/2018 | Weihansi Shengwu | Angel Round | 0 |
5/2018 | HeRui BioMed | Series A | 1.6M |
12/2016 | Xsleep | Angel Round | 431.1k |
10/2016 | LinkLab | Series B | 3M |
8/2015 | Gu Xiaofan | Angel Round | 0 |
3/2019 | Gaochun Pharmaceutical | Corporate Round | - |
1/2016 | LinkLab | Series A | 1.5M |
9/2015 | C-doctor | Angel Round | 1.6M |
12/2019 | Elpiscience Biopharmaceuticals | Series B | 0 |
6/2018 | INGEEK | Angel Round | 0 |
7/2020 | OBiO Technology | Series C | 0 |
12/2019 | Elpiscience Biopharmaceuticals | Series B | 0 |
3/2019 | Gaochun Pharmaceutical | Corporate Round | - |
12/2018 | Cryofocus Biotech | Series A | 0 |
8/2018 | BANGBANG ROBOT | Series A | - |
6/2018 | Weihansi Shengwu | Angel Round | 0 |
6/2018 | INGEEK | Angel Round | 0 |
5/2018 | HeRui BioMed | Series A | 0 |
5/2017 | Hongfund Financial | Angel Round | 0 |
5/2017 | Yuan Qu | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|